MOHEALTH provides exposure to the healthcare sector, including healthcare products, services and related businesses. Its performance is influenced by healthcare spending, medical demand and the adoption of healthcare technologies. Rising healthcare expenditure, increasing insurance coverage and expansion of medical infrastructure provide long-term opportunities. Regulatory requirements, operating costs, technology changes, healthcare demand and competition remain important factors.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | Beta |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 0.58 |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✓ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 41.48 ✓ Within 25% of the 52-week high · high 53.06 ✗ RS percentile 70 or more · RS 61 Trend template - the gate, measured: a modest 21-day edge. | 5/8 | 5 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 2 - advancing | |
| CAN SLIM | — C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✓ N within 15% of the 52-week high · high 53.06 ✓ S more volume on up days than down days (50 sessions) · 1.03x ✗ L RS percentile 80 or more · RS 61 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 3/4 | Average |
| Darvas | ✓ Box top confirmed (3 sessions below the new high) · top 53.89 ✗ Box bottom confirmed (3 sessions holding) · bottom 48.03 ✗ Close above the box top · close 48.65 ✗ Volume at least 1.5x its 50-day average · 0.9x Nicolas Darvas's box: buy the breakout above a confirmed box after a new high. | 58/100 | In box |
| Turtle | ✗ Close above the prior 55-session high · 53.89 ✗ Close above the prior 20-session high · 53.89 ✗ Close below the prior 20-session low · 48.03 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Graham | Needs positive earnings and book value. | Not assessable |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOHEALTH this stock | -6.6 | -5.1 | +10.5 | +6.8 | +68.5 | — | — | — | — | — | — | — | — | — | — | — | — | 0.58 |
| SHAILY | -1.4 | +8.7 | +68.2 | +30.0 | +747.9 | — | 65.5 | 19.93 | 26.9 | 29.3 | — | 0.24 | 50.2 | 14,284 | 1,271 | 218 | 47.4 | 0.51 |
| TARSONS | +3.0 | +12.1 | +48.2 | +8.4 | -36.2 | — | 150.8 | 2.64 | 2.3 | 4.5 | — | 0.60 | 15.1 | 1,677 | 441 | 11 | 2.1 | 1.15 |
| NURECA | -9.4 | +10.9 | +20.7 | +8.3 | -13.6 | -82.8 | 61.3 | 1.65 | 1.1 | 3.3 | — | 0.00 | 36.9 | 299 | 187 | 5 | 5.1 | 1.07 |
| POLYMED | -10.2 | -9.9 | +6.5 | -18.6 | +12.4 | +64.4 | 49.9 | 5.06 | 11.0 | 13.7 | — | 0.11 | 29.6 | 15,718 | 1,997 | 313 | 31.1 | 0.91 |
| GLOTTIS | -8.6 | -17.8 | -3.1 | -23.9 | — | — | 13.4 | 1.79 | 13.7 | — | — | 0.18 | 9.9 | 503 | — | — | 4.2 | 0.98 |
| AMRUTANJAN | +1.1 | -8.7 | -8.3 | -30.8 | -16.9 | -46.4 | 26.7 | 3.90 | 16.6 | 22.4 | — | 0.00 | 17.5 | 1,443 | 512 | 54 | 18.7 | 0.51 |
| LAXMIDENTL | -8.2 | -18.9 | -6.0 | -42.1 | — | — | 32.1 | 4.11 | 12.8 | 13.1 | — | 0.00 | 21.8 | 999 | 287 | 31 | 5.7 | 1.19 |